These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 6340824
21. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity. Ahsan CR, Sasaki J. FEBS Lett; 1991 Aug 19; 288(1-2):77-80. PubMed ID: 1715293 [Abstract] [Full Text] [Related]
22. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria. Brunda MJ, Mathews HL, Ferguson HR, McClatchy JK, Minden P. Cancer Res; 1980 Sep 19; 40(9):3211-3. PubMed ID: 6775802 [Abstract] [Full Text] [Related]
23. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid. Hanna MG, Pollack VA, Peters LC, Hoover HC. Cancer; 1982 Feb 15; 49(4):659-64. PubMed ID: 7055781 [Abstract] [Full Text] [Related]
24. Mouse Lewis lung carcinoma and hepatoma ascites treatment by combination of liposome chemotherapy and non-specific immunotherapy. Patel KR, Baldeschwieler JD. Int J Cancer; 1984 Nov 15; 34(5):717-23. PubMed ID: 6389375 [Abstract] [Full Text] [Related]
25. Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons. Yarkoni E, Rapp HJ. Infect Immun; 1978 Sep 15; 21(3):1029-32. PubMed ID: 361572 [Abstract] [Full Text] [Related]
26. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine. Hanna MG, Peters LC. Cancer Res; 1978 Jan 15; 38(1):204-9. PubMed ID: 201374 [Abstract] [Full Text] [Related]
27. Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin. Sakita M, Takenaka A, Yamane T, Kasuga M, Fujita Y, Majima S. Jpn J Surg; 1984 Sep 15; 14(5):413-9. PubMed ID: 6392656 [Abstract] [Full Text] [Related]
32. Immunotherapy of guinea pig cancer with BCG. Zbar B, Rapp HJ. Cancer; 1974 Oct 15; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315 [No Abstract] [Full Text] [Related]
33. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor. Minden P, Mathews HL, Kelleher PJ. J Immunol; 1980 Dec 15; 125(6):2685-9. PubMed ID: 7000904 [No Abstract] [Full Text] [Related]
34. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity. Sano H, Kosugi A, Sano S, Fujiwara H, Hamaoka T. Cancer Immunol Immunother; 1987 Dec 15; 25(3):180-4. PubMed ID: 2960447 [Abstract] [Full Text] [Related]
37. Enhancement of tumor growth following immunization with Bacillus Calmette-Guérin cell walls. Wepsic HT, Harris S, Sander J, Alaimo J, Morris H. Cancer Res; 1976 Jun 15; 36(6):1950-3. PubMed ID: 178437 [Abstract] [Full Text] [Related]
38. Effect of isoniazid on BCG-mediated tumor immunity. Romolo JL, Loyd B, Cohen MH. Surg Forum; 1977 Jun 15; 28():158-9. PubMed ID: 364713 [No Abstract] [Full Text] [Related]
39. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer. Key ME, Brandhorst JS, Hanna MG. J Immunol; 1983 Jun 15; 130(6):2987-92. PubMed ID: 6304194 [Abstract] [Full Text] [Related]
40. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria. Yarkoni E, Rapp HJ. Cancer Res; 1979 Feb 15; 39(2 Pt 1):535-7. PubMed ID: 761228 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]